WMG Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Sell
484
-36
-7% -$36.8K 0.22% 48
2026
Q1
$478K Sell
520
-120
-19% -$122K 0.2% 48
2025
Q4
$688K Sell
640
-247
-28% -$236K 0.28% 49
2025
Q3
$677K Buy
887
+15
+2% +$11.2K 0.23% 68
2025
Q2
$680K Sell
872
-87
-9% -$67.6K 0.25% 59
2025
Q1
$792K Buy
959
+9
+0.9% +$7.49K 0.34% 48
2024
Q4
$733K Buy
950
+471
+98% +$390K 0.32% 50
2024
Q3
$424K Buy
+479
New +$431K 0.19% 77
2024
Q2
Sell
-323
Closed -$251K 164
2024
Q1
$251K Buy
+323
New +$230K 0.14% 113

Other funds holding LLY

WMG Financial Advisors's LLY Position: Q2 2026 in Review

WMG Financial Advisors reduced its Eli Lilly (LLY) stake by 6.9% in Q2 2026, selling an estimated $36.8K and leaving 484 shares worth $581K. The position accounts for 0.22% of the portfolio, ranked #48.

WMG Financial Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $792K in Q1 2025. 1,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WMG Financial Advisors held 484 shares of Eli Lilly worth $581K as of Q2 2026.
  • WMG Financial Advisors sold 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.22% of WMG Financial Advisors's portfolio in Q2 2026, its #48 holding.
  • WMG Financial Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • WMG Financial Advisors's Eli Lilly position peaked at $792K in Q1 2025.
  • 1,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WMG Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.